Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7728725 | 0.91 | TRPV4 (0.33) | TRPV4GRM2 | |
| SCHEMBL7728734 | 0.91 | TRPV4 (0.33) | TRPV4GRM2 | |
| SCHEMBL7728730 | 0.91 | TRPV4 (0.33) | TRPV4GRM2 | |
| SCHEMBL2847034 | 0.90 | TRPV4 (0.33) | TRPV4GRM2 | |
| SCHEMBL7737283 | 0.89 | TRPV4 (0.36) | TRPV4GRM2 | |
| SCHEMBL7737281 | 0.89 | TRPV4 (0.36) | TRPV4GRM2 | |
| SCHEMBL2853742 | 0.85 | — | — | |
| SCHEMBL2858388 | 0.83 | ALOX5 (0.31) | — | |
| SCHEMBL8973188 | 0.83 | GRM2 (0.32) | TRPV4GRM2 | |
| SCHEMBL8973194 | 0.83 | GRM2 (0.32) | TRPV4GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100264368-A1 | LIQUID CRYSTAL MOLECULES COMPRISING HYDROAZULENE STRUCTURES | TETRAGON-CHEMIE AG (LI) | 2010-10-21 | — | — | US | disclosed |
| EP-1896552-B1 | LIQUID CRYSTAL MOLECULES COMPRISING HYDROAZULENE STRUCTURES | TETRAGON CHEMIE AG (LI) | 2010-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100264368-A1 | LIQUID CRYSTAL MOLECULES COMPRISING HYDROAZULENE STRUCTURES | FLI1, F12, GTF2I | TRPV4 3034/4885GRM2 4246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.